REFERENCES
1. Seta V, Gaouar H, Badaoui A, Francès C, Barbaud A, Soria A. Low-dose provocation and skin tests in patients with hypersensitivity to gadolinium-based contrast agents. Clin Exp Allergy 2019;49:724-728.
2. Mankouri F, Gauthier A, Srisuwatchari W, et al. Hypersensitivity to gadolinium-based contrast agents: A single-center retrospective analysis over 7 years. J Allergy Clin Immunol Pract 2021;9:1746-9.e2
3. Walker DT, Davenport MS, McGrath TA, et al. Breakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: A systematic review and meta-analysis. Radiology 2020;296(2):312-321.
4. Gallardo-Higueras A, Moreno EM, Muñoz-Bellido FJ, et al. Patterns of cross-reactivity in patients with immediate hypersensitivity reactions to gadobutrol. J Investig Allergol Clin Immunol 2021;31:504-506
5. Rodriguez-Nava G, Kesler AM, Carrillo-Martin I, Gonzalez-Estrada A. Gadolinium-induced anaphylaxis with positive skin test results. Ann Allergy Asthma Immunol. 2019;122:654-655
6. Vega F, Múgica MV, Bazire R, et al. Adverse reactions to iodinated contrast media: Safety of a study protocol that includes fast full-dose parenteral challenge tests searching for an alternative contrast media. Clin Exp Allergy 2020;50:271-274.